Shalom Frager, MD
Gastroenterology · New York, NYNPI 1740523125
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,788, more than ten times the $175 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in NY, where the typical reported total is $1,827.
Across 93 payments — averaging $25.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$510
- AbbVie$411
- Gilead$204
- Takeda Pharmaceuticals U.S.A., Inc.$186
- Mallinckrodt Hospital Products Inc.$181
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$165
- plus $723 from 12 others
What the payments were for
- Food & beverage$2,379100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $510 |
| AbbVie | 18 | $411 |
| Gilead | 8 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $186 |
| Mallinckrodt Hospital Products Inc. | 4 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $165 |
| E.r. Squibb & Sons, L.L.C. | 1 | $127 |
| Biogen | 1 | $116 |
| Johnson & Johnson(2 entities) | 5 | $97 |
| Celltrion USA Inc. | 5 | $88 |
| Novo Nordisk | 3 | $65 |
| Lilly USA, LLC | 3 | $51 |
| Mirum Pharmaceuticals, Inc. | 2 | $39 |
| Amgen | 2 | $35 |
| Cook Medical LLC | 1 | $31 |
| Braintree Laboratories, Inc. | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 5 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,379 in reported general payments places this provider in the 50th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ursodiol | 18 | $1,687 |
| Carvedilol | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in New York
- David Carr LockeNew York$2M
- Arthur KornbluthNew York$1.9M
- Sonal KumarNew York$1M
- David PoppersNew York$939K
- Ellen ScherlNew York$857K
- Bruce SandsNew York$810K
- Jean Frederick ColombelNew York$786K
- Seth GrossNew York$624K
- Caterina Oneto ArayaNew York$610K
- Dana LukinNew York$491K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.